Keurig Dr Pepper (NASDAQ:KDP) Hits New 12-Month High – Should You Buy?

Keurig Dr Pepper, Inc (NASDAQ:KDP) hit a new 52-week high on Wednesday. The company traded as high as $34.88 and last traded at $34.63, with a volume of 18,645,961 shares changing hands. The stock had previously closed at $34.46.

Key Stories Impacting Keurig Dr Pepper

Here are the key news stories impacting Keurig Dr Pepper this week:

• Positive Sentiment: JPMorgan raised its price target on KDP from $38 to $39 and maintained an “overweight” rating, implying further upside from recent trading levels. JPMorgan KDP price target report
• Positive Sentiment: Investor optimism around JDE Peet’s is strengthening. A bullish thesis argues that the $18.2 billion acquisition, combined with KDP’s plan to separate its refreshment-beverage and global-coffee businesses, could create more focused companies and unlock value. JDE Peet’s recently contributed revenue and operating income above expectations, while KDP reaffirmed its 2026 earnings guidance. KDP JDE Peet’s acquisition and split analysis
• Positive Sentiment: Sector rotation is supporting KDP. Beverage stocks have been among the strongest performers within the recovering consumer-staples sector, with KDP, Coca-Cola and Monster Beverage all delivering substantial year-to-date gains. KDP’s golden-cross technical pattern, support from its 50-day moving average and non-overbought RSI may attract additional momentum investors. Consumer staples and beverage stock analysis
• Neutral Sentiment: KDP is expected to report third-quarter 2026 results on November 3. Investors will focus on whether management reaffirms or raises earnings guidance and demonstrates progress toward its year-end leverage target.
• Negative Sentiment: Debt remains a key risk. The JDE Peet’s transaction increased leverage, and the bullish restructuring case depends partly on KDP reducing leverage toward its 4.1-times target. Any earnings-guidance cut or slower deleveraging could undermine the recent re-rating.
• Negative Sentiment: A federal court rejected Keurig’s effort to end a long-running antitrust lawsuit, allowing claims involving alleged monopolization, tying and false advertising to proceed to trial. The litigation creates potential legal costs, financial exposure and reputational risk. Keurig antitrust case update

Wall Street Analyst Weigh In

KDP has been the subject of a number of research reports. Argus reaffirmed a “buy” rating and issued a $36.00 price objective on shares of Keurig Dr Pepper in a report on Tuesday, September 15th. Barclays increased their target price on shares of Keurig Dr Pepper from $36.00 to $38.00 and gave the stock an “overweight” rating in a report on Monday, August 10th. Piper Sandler reissued an “overweight” rating on shares of Keurig Dr Pepper in a report on Wednesday, October 14th. The Goldman Sachs Group upgraded shares of Keurig Dr Pepper from a “neutral” rating to a “neutral” rating in a research report on Thursday, June 25th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $42.00 price target on shares of Keurig Dr Pepper in a report on Tuesday, August 4th. Eleven investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Keurig Dr Pepper has a consensus rating of “Moderate Buy” and a consensus price target of $36.07.

Keurig Dr Pepper Stock Performance

The stock has a market capitalization of $47.89 billion, a P/E ratio of 35.55, a P/E/G ratio of 1.64 and a beta of 0.40. The stock has a 50 day moving average of $31.99 and a 200 day moving average of $30.60. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.28 and a current ratio of 0.48.

Keurig Dr Pepper (NASDAQ:KDP) last posted its earnings results on Thursday, August 6th. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. Keurig Dr Pepper had a return on equity of 10.80% and a net margin of 7.10%. The company had revenue of $7.31 billion for the quarter, compared to analysts’ expectations of $7.23 billion. During the same period last year, the business posted $0.49 earnings per share. The firm’s quarterly revenue was up 75.6% compared to the same quarter last year. Equities analysts predict that Keurig Dr Pepper, Inc will post 2.30 EPS for the current year.

Keurig Dr Pepper Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 9th. Stockholders of record on Monday, September 28th were paid a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Monday, September 28th. Keurig Dr Pepper’s payout ratio is currently 92.93%.

Insider Buying and Selling at Keurig Dr Pepper

In related news, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $32.55, for a total transaction of $390,600.00. Following the completion of the sale, the insider directly owned 84,171 shares of the company’s stock, valued at $2,739,766.05. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Angela Stephens sold 9,500 shares of the business’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $32.70, for a total value of $310,650.00. Following the sale, the vice president directly owned 55,786 shares in the company, valued at $1,824,202.20. This trade represents a 14.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.34% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Keurig Dr Pepper

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in Keurig Dr Pepper during the 2nd quarter valued at $4,697,645,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in shares of Keurig Dr Pepper in the second quarter worth $767,105,000. Bank of America Corp DE acquired a new stake in shares of Keurig Dr Pepper in the second quarter worth $281,503,000. Legal & General Group Plc acquired a new stake in shares of Keurig Dr Pepper in the second quarter worth $269,336,000. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Keurig Dr Pepper by 1.1% during the first quarter. Dimensional Fund Advisors LP now owns 9,585,791 shares of the company’s stock valued at $252,408,000 after buying an additional 103,505 shares in the last quarter. 93.99% of the stock is currently owned by hedge funds and other institutional investors.

About Keurig Dr Pepper

Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.

The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.